Ardent Health (ARDT) Cash from Financing Activities (2023 - 2026)

Ardent Health (ARDT) has reported Cash from Financing Activities for 4 consecutive years, with -$11.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 14.79% year-over-year to -$11.8 million; the TTM figure through Mar 2026 stood at -$101.4 million (down 446.21% YoY), while the FY2025 annual figure was -$103.5 million, down 519.87% from the prior year.
• Cash from Financing Activities came in at -$11.8 million for Q1 2026 at Ardent Health, up from -$37.0 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $183.4 million in Q3 2024, with the low at -$119.8 million in Q2 2024.
• Average Cash from Financing Activities over 4 years is -$12.0 million, with a median of -$20.5 million recorded in 2024.
• Across the five-year window, Cash from Financing Activities jumped 867.13% in 2024 and sank 114.68% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at -$17.9 million in 2023, then dropped by 14.48% to -$20.5 million in 2024, then tumbled by 80.88% to -$37.0 million in 2025, then jumped by 68.19% to -$11.8 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$11.8 million, -$37.0 million, and -$26.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.